Skip to content
Directory

Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals
171
currently held
Exits tracked
127
hand-checked
Sectors covered
1
across the portfolio
Countries covered
31
from every market
241 companies matching · Page 4 of 5
MPA Pharma
MPA Pharma
Hannover Finanz Evergreen Fund
Germany
Active
Sector
Pharma
InvestorHannover Finanz
Entry
1998
Hold
28yr
NEC MED PHARMA GmbH
NEC MED PHARMA GmbH
NORD Holding Mid Cap
Germany
Active
Sector
Pharma
InvestorNORD Holding
Entry
2016
Hold
10yr
Noucor
Noucor
MCH Iberian Capital Fund V
Spain
Active
Sector
Pharma
InvestorMCH Private Equity Investments
Entry
2022
Hold
4yr
Novaliq
Novaliq
dievini Hopp BioTech holding (Evergreen Balance Sheet)
Germany
Active
Sector
Pharma
Investordievini Hopp BioTech holding
Entry
2007
Hold
19yr
NTC
NTC
Wisequity V
Italy
Active
Sector
Pharma
InvestorWise Equity SGR
Entry
2022
Hold
4yr
OcuMension
OcuMension
General Atlantic Portfolio
USA
Active
Sector
Pharma
InvestorGeneral Atlantic
Entry
PerioTrap Pharmaceuticals GmbH
PerioTrap Pharmaceuticals GmbH
Fraunhofer Venture (spin-off equity)
Germany
Active
Sector
Pharma
InvestorFraunhofer Venture
Entry
2018
Hold
8yr
Pharmacom
Pharmacom
Scipio Swanlaab SF
Austria
Active
Sector
Pharma
InvestorSwanlaab Venture Factory
Entry
2025
Hold
1yr
Pharmscript
Pharmscript
Summit Partners Portfolio
USA
Active
Sector
Pharma
InvestorSummit Partners
Entry
Piramal Pharma Limited
Piramal Pharma Limited
Carlyle U.S. Private Equity Fund
India
Active
Sector
Pharma
InvestorThe Carlyle Group
Entry
PrioThera
PrioThera
Earlybird Health
Ireland
Active
Sector
Pharma
InvestorEarlybird Venture Capital
Entry
2020
Hold
6yr
ProJect Pharmaceutics
ProJect Pharmaceutics
AFINUM IX Buyout (2021)
Germany
Active
Sector
Pharma
InvestorAFINUM Management GmbH
Entry
2025
Hold
1yr
Republic M
Republic M
Queen's Park Equity Partners I
UK
Active
Sector
Pharma
InvestorQueen's Park Equity
Entry
2022
Hold
4yr
Revi Pharma
Revi Pharma
Italian Fine Food
Italy
Active
Sector
Pharma
InvestorAVM SGR
Entry
2026
Hold
0yr
Rioja Nature Pharma
Rioja Nature Pharma
Tresmares Private Equity Fund II
Spain
Active
Sector
Pharma
InvestorTresmares Capital
Entry
2023
Hold
3yr
Royalty Pharma
Royalty Pharma
General Atlantic
United States
Active
Sector
Pharma
InvestorGeneral Atlantic
Entry
Seda
Seda
BGF
UK
Active
Sector
Pharma
InvestorBGF
Entry
2025
Hold
1yr
Septodont
Septodont
CIC Debt Fund 4
France
Active
Sector
Pharma
InvestorCIC Private Debt
Entry
2023
Hold
3yr
SeQuent Scientific Limited
SeQuent Scientific Limited
Carlyle Sub-Saharan Africa Fund
India
Active
Sector
Pharma
InvestorThe Carlyle Group
Entry
Shorla Pharma
Shorla Pharma
Enterprise Ireland
Ireland
Active
Sector
Pharma
InvestorEnterprise Ireland
Entry
Start Center For Cancer Research
Start Center For Cancer Research
Warburg Pincus Global Growth 14, L.P.
United States
Active
Sector
Pharma
InvestorWarburg Pincus
Entry
ten23 health
ten23 health
3i Group plc (Evergreen balance sheet)
Switzerland
Active
Sector
Pharma
Investor3i
Entry
2021
Hold
5yr
Trifarma
Trifarma
Principia III - Health
Italy
Active
Sector
Pharma
InvestorPrincipia SGR
Entry
2017
Hold
9yr
Viyash Life Sciences Private Limited
Viyash Life Sciences Private Limited
Carlyle Asia fund
India
Active
Sector
Pharma
InvestorThe Carlyle Group
Entry
Zentiva
Zentiva
CM-CIC Debt Fund 3
Czech Republic
Active
Sector
Pharma
InvestorCIC Private Debt
Entry
2020
Hold
6yr
Zevra Therapeutics
Zevra Therapeutics
TVM Life Science Ventures
United States
Active
Sector
Pharma
InvestorTVM Capital Life Science
Entry
2023
Hold
3yr
Laboratoires Delbert
Vivalto Partners Fund I
France
Active
Sector
Pharma
InvestorVivalto Partners
Entry
2022
Hold
4yr
Owners
5
Delpharm
IDIA Small & Midcap
France
Active
Sector
Pharma
InvestorIdia
Entry
2007
Hold
5yr
Owners
4
Medincell
Crédit Mutuel Equity
France
Active
Sector
Pharma
InvestorCrédit Mutuel Equity
Entry
2017
Hold
9yr
Owners
3
Genetic
Renaissance Partners Fund IV
Italy
Active
Sector
Pharma
InvestorRenaissance Partners
Entry
2025
Hold
1yr
Owners
2
Kent Pharmaceuticals
DS Cornerstone Fund
UK
Active
Sector
Pharma
InvestorDuke Street
Entry
2019
Hold
7yr
Owners
2
Marcyrl
Amethis Fund III
Egypt
Active
Sector
Pharma
InvestorEdmond de Rothschild Private Equity (France)
Entry
2023
Hold
3yr
Owners
2
Opella
Bpifrance
Active
Sector
Pharma
InvestorBpifrance Investissement
Entry
2025
Hold
1yr
Owners
2
PharOS
Viessmann Generations Group Balance Sheet
Greece
Active
Sector
Pharma
InvestorViessmann Generations Group
Entry
2024
Hold
2yr
Owners
2
Sagitta Pharma
Acto V
France
Active
Sector
Pharma
InvestorAndera Partners
Entry
2021
Hold
5yr
Owners
2
Theramex
PAI Europe VII
United Kingdom
Active
Sector
Pharma
InvestorPAI Partners
Entry
2022
Hold
4yr
Owners
2
Abarceo Pharma
Almi Invest (Regional funds)
Sweden
Active
Sector
Pharma
InvestorAlmi Invest
Entry
2021
Hold
5yr
Advanz Pharma
Nordic Capital Fund X
United Kingdom
Active
Sector
Pharma
InvestorNordic Capital
Entry
2021
Hold
5yr
Akinion Pharmaceuticals
Rosetta Capital IV
Sweden
Active
Sector
Pharma
InvestorRosetta Capital
Entry
2013
Hold
13yr
almapharm
Armira Evergreen
Germany
Active
Sector
Pharma
InvestorArmira
Entry
2024
Hold
2yr
Aphaia Pharma
Bioventure Club Deals
Switzerland
Active
Sector
Pharma
InvestorBioventure Management
Entry
2018
Hold
8yr
Artroa AB
SLU Holding
Sweden
Active
Sector
Pharma
InvestorSLU Holding
Entry
2023
Hold
3yr
Atec Pharmatechnik GmbH
GBK Evergreen Holdings
Germany
Active
Sector
Pharma
InvestorGBK Beteiligungen AG
Entry
2022
Hold
4yr
Avia Pharma
Impilo Investment Pool 2
Sweden
Active
Sector
Pharma
InvestorImpilo
Entry
2024
Hold
2yr
Basic Pharma
SHS VI
Netherlands
Active
Sector
Pharma
InvestorSHS Gesellschaft für Beteiligungsmanagement
Entry
2026
Hold
0yr
Bohus Biotech
Flerie Invest
Sweden
Active
Sector
Pharma
InvestorFlerie
Entry
2022
Hold
4yr
Catalent
Novo Holdings Principal Investments
United States
Active
Sector
Pharma
InvestorNovo Holdings
Entry
2024
Hold
2yr
Ceva II
IXO 5
France
Active
Sector
Pharma
InvestoriXO Private Equity
Entry
2025
Hold
1yr
Cooperation Pharmaceutique
CM-CIC Debt Fund 3
France
Active
Sector
Pharma
InvestorCIC Private Debt
Entry
2021
Hold
5yr
cormeo
Bertelsmann Digital Media Investments (BDMI)
Germany
Active
Sector
Pharma
InvestorBertelsmann Investments
Entry
2025
Hold
1yr